US · Healthcare

Glass House Brands Inc (GLASF)

Drug Manufacturers - Specialty & Generic

Glass House Brands Inc (GLASF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for GLASF

P/E ratio
18.00

Glass House Brands Inc (GLASF) — FAQ

What is GLASF's P/E ratio?

The price-to-earnings (P/E) ratio for Glass House Brands Inc (GLASF) is 18.00 (data as of 2026-05-23).

Does Glass House Brands Inc pay a dividend?

Dividend yield is not available in the current snapshot for Glass House Brands Inc (GLASF). Check the MyAverix Finance app for the latest dividend data.

What sector is Glass House Brands Inc in?

Glass House Brands Inc (GLASF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is GLASF listed on?

GLASF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play